Tavanic I.V. 750 5 mg / 1ml Infusion

Tavanic I.V. 750 5 mg / 1ml Infusion

S4
PDF Leaflet Revision Date: March 2013

API: Levofloxacin | Company: Ranbaxy

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of mild bacterial infections due to levofloxacin-susceptible micro-organisms.

Dosage (summary)

750 mg IV once daily; adjust for renal impairment.

Special Populations

  • Renal impairment
  • Elderly

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Key Drug Interactions

  • Theophylline
  • Probenecid
  • Cimetidine
  • Vitamin K antagonists
  • QT-prolonging medications

Contraindications

  • Hypersensitivity to levofloxacin
  • Epilepsy
  • History of tendon disorders
  • Children or adolescents

Common side effects

  • Diarrhoea
  • Nausea
  • Headache
  • Dizziness
  • Insomnia

Counselling Points

  • Avoid exposure to strong sunlight
  • Monitor blood glucose in diabetics
  • Report any signs of tendon pain or swelling

Serious warnings

  • Risk of tendon rupture
  • Pseudomembranous colitis
  • QT-interval prolongation
Important Disclaimer

The Tavanic I.V. 750 5 mg / 1ml Infusion professional information leaflet below is the property of Ranbaxy and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites